Estradiol attenuates programmed cell death after stroke-like injury

Area of Science:

• Neuroscience
• Endocrinology
• Cell Biology

Background:

• Estradiol is recognized for its neurotrophic and neuroprotective properties.
• Previous research indicated estradiol protects the cortex from middle cerebral artery occlusion (MCAO)-induced cell death.
• Caspase-dependent programmed cell death (PCD) is a key mechanism in cerebral cortex injury during focal cerebral ischemia.

Purpose of the Study:

• To investigate if estradiol attenuates PCD during stroke injury.
• To explore the temporospatial pattern of PCD markers and their relation to injury evolution.
• To determine the modulatory effect of estradiol on PCD markers in an MCAO model.

Main Methods:

• Ovariectomized rats were treated with either estradiol or a vehicle control.
• Rats underwent MCAO, with brain tissue collected at 1, 4, 8, 16, and 24 hours post-procedure.
• Infarction volume, DNA fragmentation, and spectrin cleavage products (SBDPs) in the ischemic cortex were assessed.

Main Results:

• Estradiol delayed and attenuated MCAO-induced DNA fragmentation starting at 8 hours.
• Estradiol significantly reduced caspase-mediated spectrin breakdown product (SBDP120) at 4 hours post-MCAO.
• Estradiol did not alter SBDP150 levels, which are indicative of both caspase and calpain activity.

Conclusions:

• Estradiol protects the ischemic cortex by attenuating programmed cell death (PCD).
• The neuroprotective mechanism involves reduced caspase activity and DNA fragmentation.
• These findings enhance the understanding of estrogen-mediated neuroprotection in stroke.